Results: 1-25 | 26-33
Results: 1-25/33

Authors: Takebe, N Zhao, SC Adhikari, D Mineishi, S Sadelain, M Hilton, J Colvin, M Banerjee, D Bertino, JR
Citation: N. Takebe et al., Generation of dual resistance to 4-hydroperoxycyclophosphamide and methotrexate by retroviral transfer of the human aldehyde dehydrogenase class 1 gene and a mutated dihydrofolate reductase gene, MOL THER, 3(1), 2001, pp. 88-96

Authors: Li, WW Takahashi, N Jhanwar, S Cordon-Cardo, C Elisseyeff, Y Jimeno, J Faircloth, G Bertino, JR
Citation: Ww. Li et al., Sensitivity of soft tissue sarcoma cell lines to chemotherapeutic agents: Identification of ecteinascidin-743 as a potent cytotoxic agent, CLIN CANC R, 7(9), 2001, pp. 2908-2911

Authors: Takahashi, N Li, WW Banerjee, D Scotto, KW Bertino, JR
Citation: N. Takahashi et al., Sequence-dependent enhancement of cytotoxicity produced by ecteinascidin 743 (ET-743) with doxorubicin or paclitaxel in soft tissue sarcoma cells, CLIN CANC R, 7(10), 2001, pp. 3251-3257

Authors: Sapse, AM Capiaux, GM Bertino, JR
Citation: Am. Sapse et al., Examination of the reduced affinity of the thymidylate synthase G52S mutation for FdUMP by ab initio and semi-empirical studies, MOL MED, 7(3), 2001, pp. 200-204

Authors: Longo-Sorbello, GSA Bertino, JR
Citation: Gsa. Longo-sorbello et Jr. Bertino, Current understanding of methotrexate pharmacology and efficacy in acute leukemias. Use of newer antifolates in clinical trials, HAEMATOLOG, 86(2), 2001, pp. 121-127

Authors: Li, WW Fan, JG Bertino, JR
Citation: Ww. Li et al., Selective sensitization of retinoblastoma protein-deficient sarcoma cells to doxorubicin by ravopiridol-mediated inhibition of cyclin-dependent kinase 2 kinase activity, CANCER RES, 61(6), 2001, pp. 2579-2582

Authors: Trippett, TM Garcia, S Manova, K Mody, R Cohen-Gould, L Flintoff, W Bertino, JR
Citation: Tm. Trippett et al., Localization of a human reduced folate carrier protein in the mitochondrial as well as the cell membrane of leukemia cells, CANCER RES, 61(5), 2001, pp. 1941-1947

Authors: Cole, PD Kamen, BA Gorlick, R Banerjee, D Smith, AK Magill, E Bertino, JR
Citation: Pd. Cole et al., Effects of overexpression of gamma-glutamyl hydrolase on methotrexate metabolism and resistance, CANCER RES, 61(11), 2001, pp. 4599-4604

Authors: Moskowitz, CH Nimer, SD Zelenetz, AD Trippett, T Hedrick, EE Filippa, D Louie, D Gonzales, M Walits, J Coady-Lyons, N Qin, J Frank, R Bertino, JR Coy, A Noy, A O'Brien, JP Straus, D Portlock, CS Yahalom, J
Citation: Ch. Moskowitz et al., A 2-step comprehensive high-dose chemoradiotherapy second-line program forrelapsed and refractory Hodgkin disease: analysis by intent to treat and development of a prognostic model, BLOOD, 97(3), 2001, pp. 616-623

Authors: Levy, AS Meyers, P Kellick, M Gorlick, R Tong, W Bertino, JR
Citation: As. Levy et al., Acute stroke-like encephalopathy associated with high-dose methotrexate impurities, J PED H ONC, 22(4), 2000, pp. 360-362

Authors: Longo, GSA Izzo, J Gorlick, R Banerjee, D Jhanwar, SC Bertino, JR
Citation: Gsa. Longo et al., Characterization and drug sensitivity of four newly established colon adenocarcinoma cell lines to antifolate inhibitors of thymidylate synthase, ONCOL RES, 12(8), 2000, pp. 309-314

Authors: Srimatkandada, S Dube, SK Carmen, M Bertino, JR
Citation: S. Srimatkandada et al., Coamplification of 3-hydroxy-3-methylglutaryl coenzyme A reductase genes in methotrexate-resistant human leukemia cell lines, ONCOL RES, 12(1), 2000, pp. 11-15

Authors: Takebe, N Nakahara, S Zhao, SC Adhikari, D Ural, AU Iwamoto, M Banerjee, D Bertino, JR
Citation: N. Takebe et al., Comparison of methotrexate resistance conferred by a mutated dihydrofolatereductase (DHFR) cDNA in two different retroviral vectors, CANC GENE T, 7(6), 2000, pp. 910-919

Authors: Ural, AU Takebe, N Adhikari, D Ercikan-Abali, E Banerjee, D Barakat, R Bertino, JR
Citation: Au. Ural et al., Gene therapy for endometrial carcinoma with the herpes simplex thymidine kinase gene, GYNECOL ONC, 76(3), 2000, pp. 305-310

Authors: Banerjee, D Gorlick, R Liefshitz, A Danenberg, K Danenberg, PC Danenberg, PV Klimstra, D Jhanwar, S Cordon-Cardo, C Fong, Y Kemeny, N Bertino, JR
Citation: D. Banerjee et al., Levels of E2F-1 expression are higher in lung metastasis of colon cancer as compared with hepatic metastasis and correlate with levels of thymidylatesynthase, CANCER RES, 60(9), 2000, pp. 2365-2367

Authors: Martin, DS Bertino, JR Koutcher, JA
Citation: Ds. Martin et al., ATP depletion plus pyrimidine depletion can markedly enhance cancer therapy: Fresh insight for a new approach, CANCER RES, 60(24), 2000, pp. 6776-6783

Authors: Trippett, TM Bertino, JR
Citation: Tm. Trippett et Jr. Bertino, Therapeutic strategies targeting proteins that regulate folate and reducedfolate transport, J CHEMOTHER, 11(1), 1999, pp. 3-10

Authors: Guo, W Healey, JH Meyers, PA Ladanyi, M Huvos, AG Bertino, JR Gorlick, R
Citation: W. Guo et al., Mechanisms of methotrexate resistance in osteosarcoma, CLIN CANC R, 5(3), 1999, pp. 621-627

Authors: Sauerbrey, A McPherson, JP Zhao, SC Banerjee, D Bertino, JR
Citation: A. Sauerbrey et al., Expression of a novel double-mutant dihydrofolate reductase-cytidine deaminase fusion gene confers resistance to both methotrexate and cytosine arabinoside, HUM GENE TH, 10(15), 1999, pp. 2495-2504

Authors: Kooby, DA Carew, JF Halterman, MW Mack, JE Bertino, JR Blumgart, LH Federoff, HJ Fong, YM
Citation: Da. Kooby et al., Oncolytic viral therapy for human colorectal cancer and liver metastases using a multi-mutated herpes simplex virus type-1 (G207), FASEB J, 13(11), 1999, pp. 1325-1334

Authors: Sapse, DS Tong, YZ Bertino, JR Sapse, AM
Citation: Ds. Sapse et al., Ab initio studies of some amino acid residue complexes with 4-mercaptopyridine as a model for Thymitaq (AG337), an inhibitor of thymidylate synthase, CANCER INV, 17(6), 1999, pp. 396-401

Authors: Moskowitz, CH Bertino, JR Glassman, JR Hedrick, EE Hunte, S Coady-Lyons, N Agus, DB Goy, A Jurcic, J Noy, A O'Brien, J Portlock, CS Straus, DS Childs, B Frank, R Yahalom, J Filippa, D Louie, D Nimer, SD Zelenetz, AD
Citation: Ch. Moskowitz et al., Ifosfamide, carboplatin, and etoposide: A highly effective cytoreduction and peripheral-blood progenitor-cell mobilization regimen for transplant-eligible patients with non-Hodgkin's lymphoma, J CL ONCOL, 17(12), 1999, pp. 3776-3785

Authors: Hochhauser, D Valkov, NI Gump, JL Wei, I O'Hare, C Hartley, J Fan, JG Bertino, JR Banerjee, D Sullivan, DM
Citation: D. Hochhauser et al., Effects of wild-type p53 expression on the quantity and activity of topoisomerase II alpha and beta in various human cancer cell lines, J CELL BIOC, 75(2), 1999, pp. 245-257

Authors: Moskowitz, CH Nimer, SD Glassman, JR Portlock, CS Yahalom, J Straus, DJ O'Brien, JP Elkin, N Bertino, JR Zelenetz, AD
Citation: Ch. Moskowitz et al., The International Prognostic Index predicts for outcome following autologous stem cell transplantation in patients with relapsed and primary refractory intermediate-grade lymphoma, BONE MAR TR, 23(6), 1999, pp. 561-567

Authors: Gorlick, R Bertino, JR
Citation: R. Gorlick et Jr. Bertino, Drug resistance in colon cancer, SEMIN ONCOL, 26(6), 1999, pp. 606-611
Risultati: 1-25 | 26-33